These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37604217)

  • 1. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
    Fukuhara H; Hagiwara Y; Oba K; Inoue K
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
    Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
    Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K
    Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
    Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
    Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H
    Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Real-life experience': recurrence rate at 3 years with Hexvix
    Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
    World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.
    Heer R; Lewis R; Vadiveloo T; Yu G; Mariappan P; Cresswell J; McGrath J; Nabi G; Mostafid H; Lazarowicz H; Kelly J; Duncan A; Penegar S; Breckons M; Wilson L; Clark E; Feber A; Orozco-Leal G; Tandogdu Z; Taylor E; N'Dow J; Norrie J; Ramsay C; Rice S; Vale L; MacLennan G; Hall E
    NEJM Evid; 2022 Oct; 1(10):EVIDoa2200092. PubMed ID: 38319866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial.
    Yu G; Rice S; Heer R; Lewis R; Vadiveloo T; Mariappan P; Penegar S; Clark E; Tandogdu Z; Hall E; Vale L
    Eur Urol Open Sci; 2023 Jul; 53():67-77. PubMed ID: 37441343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation on the Usefulness of Photodynamic Diagnosis-assisted Targeted Bladder Biopsy: Japanese Real-world Study.
    Arai T; Sazuka T; Oka R; Tsukamoto R; Sato H; Goto Y; Imamura Y; Sakamoto S; Ichikawa T
    Anticancer Res; 2023 Aug; 43(8):3615-3621. PubMed ID: 37500129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.
    Nohara T; Kamijima T; Fukuda R; Kano H; Shimada T; Nakano T; Kato Y; Kadomoto S; Iwamoto H; Yaegashi H; Iijima M; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102628. PubMed ID: 34808397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
    Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
    Yamamoto S; Fukuhara H; Karashima T; Inoue K
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():101999. PubMed ID: 32920180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of photodynamic diagnosis with oral 5-aminolevulinic acid for upper tract- and bladder urothelial carcinoma: a single-centre, retrospective analysis.
    Sano T; Yoshida T; Nakamoto T; Ohe C; Taniguchi H; Yanishi M; Kinoshita H
    World J Urol; 2024 Jul; 42(1):389. PubMed ID: 38985343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
    Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
    Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
    Nakagawa R; Nohara T; Kano H; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Mizokami A
    Photodiagnosis Photodyn Ther; 2024 Apr; 46():104023. PubMed ID: 38401816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.